Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
For many medtech companies, Asia still holds significant opportunity compared to the persistent slow growth in the more mature US and European markets. But those looking to do business in this region need to plan long term. The biggest mistake is to think you can make a quick buck, says Abel Ang, CEO of Accuron Medtech, Southeast Asia's largest medical device pure-play. The Singapore-based industry veteran shares with Medtech Insight the lessons he learned from his time building businesses for medtech multinationals in APAC and other international markets. He also gives tips from his current experience introducing a disruptive technology to this region.
As Katarzyna Mazur-Hofsäss approaches her fifth anniversary as head of Zimmer Biomet's EMEA division, she chats with Medtech Insight about her concerns as medical device companies operating in Europe try to cope with the new regulatory environment and how the orthopedics giant is responding to new demands from health-care providers.
Precision health is gathering momentum and this trend brings opportunities for companies to enable a more tailored approach to health care. GE Healthcare's chief strategy and commercial officer Tom McGuinness tells Medtech Insight how the health-tech giant has been working to "connect the dots" to make precision health a reality, and in doing so is allowing the company to sustain growth and stay on top in an evolving landscape.
Hindsight 20/20 is a Q&A feature where medtech industry veterans share their experience taking diverse businesses – be they start-ups or publicly listed entities – from strength to strength and navigating through times of crises. In this installment, Yossi Gross, Israeli serial entrepreneur and founding partner of medtech incubator and investor Rainbow Medical, explains why getting regulators involved in your clinical strategy sets you on the right path to success and shares a hard lesson he learned about letting a strategic partner have too much control.
Hindsight 20/20 is a Q&A feature where medtech industry veterans share their experience taking diverse businesses – be they start-ups or publicly listed entities – from strength to strength and navigating through times of crises. In this installment, Mark Hitchman, managing director of Canon Medical Systems Europe, shares insights on how to grow your business' market share and get that one-up over your competitors, as well as how to remain a market leader once you reach the top.
Josh Blackmore recently joined M Holland Co., a leading distributor of thermoplastic resin, as its global healthcare manager to help expand the company's participation in the medical device industry. He provides insight on the importance of plastics and how this material plays an important role in helping to drive medical device-makers innovate.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.